{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:37:01Z","timestamp":1781523421458,"version":"3.54.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00123","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T11:24:25Z","timestamp":1582284265000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Ascorbic Acid Sensitizes Colorectal Carcinoma to the Cytotoxicity of Arsenic Trioxide via Promoting Reactive Oxygen Species-Dependent Apoptosis and Pyroptosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Wei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-nan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Feng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,21]]},"reference":[{"key":"B1","first-page":"4555","article-title":"Stromal cell oxidation: a mechanism by which tumors obtain vitamin C","volume":"59","author":"Agus","year":"1999","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/ijo.30.2.313","article-title":"Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells","volume":"30","author":"Baysan","year":"2007","journal-title":"Int. J. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.leukres.2010.01.020","article-title":"Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro","volume":"34","author":"Biswas","year":"2010","journal-title":"Leuk Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1182\/blood-2006-04-020610","article-title":"Arsenic trioxide: a promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL\/lpr mice","volume":"108","author":"Bobe","year":"2006","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/hon.870","article-title":"Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a wisconsin oncology network study","volume":"27","author":"Chang","year":"2009","journal-title":"Hematol. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1053\/j.gastro.2011.10.002","article-title":"Inflammasomes in intestinal inflammation and cancer","volume":"141","author":"Chen","year":"2011","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","article-title":"In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha\/PML proteins","volume":"88","author":"Chen","year":"1996","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/bph.13765","article-title":"Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer","volume":"174","author":"Chen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvs230","article-title":"Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome","volume":"96","author":"Chu","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0959-8049(95)00059-R","article-title":"Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines","author":"De Laurenzi","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/cdd.2014.117","article-title":"Liver X receptor beta activation induces pyroptosis of human and murine colon cancer cells","volume":"21","author":"Derangere","year":"2014","journal-title":"Cell Death Differ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1158\/1535-7163.MCT-13-0234","article-title":"Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC","volume":"12","author":"Dinnen","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.lfs.2016.10.020","article-title":"Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells","volume":"167","author":"Eyvani","year":"2016","journal-title":"Life Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3322\/canjclin.55.3.178","article-title":"Targeting apoptosis pathways in cancer therapy","volume":"55","author":"Ghobrial","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"B19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.toxlet.2016.06.019","article-title":"Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells","volume":"258","author":"Gong","year":"2016","journal-title":"Toxicol. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy","volume":"19","author":"Hoffer","year":"2008","journal-title":"Ann. Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-4274(02)00084-X","article-title":"Arsenic toxicity and potential mechanisms of action","volume":"133","author":"Hughes","year":"2002","journal-title":"Toxicol. Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1161\/01.HYP.0000157169.27818.ae","article-title":"Mitochondria-derived reactive oxygen species and vascular MAP kinases: comparison of angiotensin II and diazoxide","volume":"45","author":"Kimura","year":"2005","journal-title":"Hypertension"},{"key":"B24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.toxlet.2013.03.024","article-title":"Arsenic trioxide induces cardiac fibroblast apoptosis in vitro and in vivo by up-regulating TGF-beta1 expression","volume":"219","author":"Li","year":"2013","journal-title":"Toxicol. Lett."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20455\/ros.2016.803","article-title":"Defining ROS in biology and medicine","volume":"1","author":"Li","year":"2016","journal-title":"React Oxyg Species (Apex)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00271","article-title":"Inflammasomes in inflammation-induced cancer","volume":"8","author":"Lin","year":"2017","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"222ra218","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4049\/jimmunol.1301434","article-title":"Arsenic trioxide and other arsenical compounds inhibit the NLRP1, NLRP3, and NAIP5\/NLRC4 inflammasomes","volume":"192","author":"Maier","year":"2014","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1476-5381.2009.00282.x","article-title":"Vitamin C: update on physiology and pharmacology","volume":"157","author":"Mandl","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.freeradbiomed.2008.10.049","article-title":"TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction","volume":"46","author":"Mariappan","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"12595","DOI":"10.1038\/ncomms12595","article-title":"Stratification and therapeutic potential of PML in metastatic breast cancer","volume":"7","author":"Martin-Martin","year":"2016","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1200\/JCO.2010.28.5031","article-title":"Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data","volume":"28","author":"Mathews","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"222fs226","DOI":"10.1126\/scitranslmed.3008488","article-title":"Ascorbate combination therapy: new tool in the anticancer toolbox?","volume":"6","author":"McConnell","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/ni.1960","article-title":"Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria","volume":"11","author":"Miao","year":"2010","journal-title":"Nat. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM198501173120301","article-title":"High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. a randomized double-blind comparison","volume":"312","author":"Moertel","year":"1985","journal-title":"N Engl. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1158\/1535-7163.MCT-08-0595","article-title":"Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells","volume":"8","author":"Pettersson","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0306-9877(95)90137-x","article-title":"Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent","volume":"44","author":"Riordan","year":"1995","journal-title":"Med. Hypotheses"},{"key":"B38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ctrv.2009.04.007","article-title":"The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review","volume":"35","author":"Rollig","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1221S","DOI":"10.1093\/jn\/126.suppl_4.1221S","article-title":"The dual roles of nutrients as antioxidants and prooxidants: their effects on tumor cell growth","volume":"126","author":"Schwartz","year":"1996","journal-title":"J. Nutr."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1080\/15384101.2017.1387699","article-title":"Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells","volume":"16","author":"Shi","year":"2017","journal-title":"Cell Cycle"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1753425910371668","article-title":"Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-kappaB down-regulation and caspase-3 activation","volume":"17","author":"Singer","year":"2011","journal-title":"Innate Immun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1182\/blood-2006-01-0054","article-title":"Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety","volume":"108","author":"Siu","year":"2006","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00280-013-2179-9","article-title":"Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer","volume":"72","author":"Stephenson","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12029-014-9617-8","article-title":"In the war against solid tumors arsenic trioxide needs partners","volume":"45","author":"Subbarayan","year":"2014","journal-title":"J. Gastrointest Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/02841860601042456","article-title":"Arsenic trioxide\/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: a clinical experience","volume":"46","author":"Subbarayan","year":"2007","journal-title":"Acta Oncol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s13046-019-1295-8","article-title":"Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms","volume":"38","author":"Tan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0006-2952(01)00606-2","article-title":"Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide","volume":"61","author":"Vernhet","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","article-title":"Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects","volume":"47","author":"Verrax","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e67081","DOI":"10.1371\/journal.pone.0067081","article-title":"Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells","volume":"8","author":"Vuyyuri","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00432-014-1659-6","article-title":"Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro","volume":"140","author":"Wang","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2019.02.014","article-title":"Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497\/PELP1 axis","volume":"450","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.6-suppl_2-3","article-title":"History of the development of arsenic derivatives in cancer therapy","author":"Waxman","year":"2001","journal-title":"Oncologist"},{"key":"B55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ebiom.2017.02.011","article-title":"Multiple myeloma tumor cells are selectively killed by pharmacologically-dosed ascorbic acid","volume":"18","author":"Xia","year":"2017","journal-title":"EBioMedicine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10637-015-0301-z","article-title":"Anti-tumoral effect of arsenic compound, sodium metaarsenite (KML001), in non-Hodgkin\u2019s lymphoma: an in vitro and in vivo study","volume":"34","author":"Yoon","year":"2016","journal-title":"Invest. New Drugs"},{"key":"B58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamaoncol.2017.0417","article-title":"An international collaborative standardizing a comprehensive patient-centered outcomes measurement set for colorectal cancer","volume":"3","author":"Zerillo","year":"2017","journal-title":"JAMA Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1742-7843.2007.00150.x","article-title":"Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity","volume":"102","author":"Zhao","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41422-018-0090-y","article-title":"Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis","volume":"28","author":"Zhou","year":"2018","journal-title":"Cell Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T11:24:27Z","timestamp":1582284267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,21]]},"references-count":60,"alternative-id":["10.3389\/fphar.2020.00123"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00123","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,21]]},"article-number":"123"}}